HEFFLER, Enrico Marco
 Distribuzione geografica
Continente #
NA - Nord America 6.939
EU - Europa 1.760
AS - Asia 928
AF - Africa 271
OC - Oceania 41
SA - Sud America 36
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.982
Nazione #
US - Stati Uniti d'America 6.854
SG - Singapore 417
FI - Finlandia 385
IE - Irlanda 310
NG - Nigeria 259
DE - Germania 252
CN - Cina 239
IT - Italia 212
FR - Francia 134
NL - Olanda 117
GB - Regno Unito 82
CA - Canada 69
SE - Svezia 67
IN - India 61
TW - Taiwan 39
AU - Australia 37
CZ - Repubblica Ceca 37
TR - Turchia 35
KR - Corea 33
BE - Belgio 32
BR - Brasile 29
RU - Federazione Russa 28
HK - Hong Kong 24
CH - Svizzera 23
ES - Italia 21
JP - Giappone 19
IL - Israele 18
MX - Messico 15
PK - Pakistan 9
RO - Romania 8
ID - Indonesia 7
NO - Norvegia 7
PL - Polonia 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AT - Austria 5
DK - Danimarca 5
GR - Grecia 5
IQ - Iraq 5
SA - Arabia Saudita 5
EG - Egitto 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
UA - Ucraina 4
AR - Argentina 3
GM - Gambi 3
IR - Iran 3
MY - Malesia 3
PT - Portogallo 3
TH - Thailandia 3
VN - Vietnam 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
BG - Bulgaria 2
CL - Cile 2
CO - Colombia 2
DZ - Algeria 2
EU - Europa 2
HR - Croazia 2
HU - Ungheria 2
MD - Moldavia 2
SI - Slovenia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
ET - Etiopia 1
LV - Lettonia 1
MA - Marocco 1
PA - Panama 1
PH - Filippine 1
ZA - Sudafrica 1
Totale 9.982
Città #
Chandler 1.322
Wilmington 1.289
San Mateo 482
Ann Arbor 415
Helsinki 383
Dublin 291
Singapore 269
Benin City 259
Boardman 245
Lawrence 234
Princeton 234
Leawood 221
Shanghai 181
New York 155
Fairfield 124
Ashburn 115
Paris 107
Woodbridge 107
Amsterdam 92
Toronto 57
London 51
Seattle 44
Santa Clara 38
San Diego 35
Redwood City 34
Kocaeli 30
Norwalk 30
Brussels 29
Menlo Park 28
Pune 22
Monmouth Junction 21
Munich 21
Brno 20
Milan 19
Los Angeles 18
Newark 17
Phoenix 16
Falls Church 15
Buffalo 12
Houston 11
Melbourne 11
Hyderabad 10
Moscow 10
Redmond 10
Prague 9
Beijing 8
Des Moines 8
Olomouc 8
Pergine Valsugana 8
Rome 8
Turin 8
Cambridge 7
Falkenstein 7
Genoa 7
Jakarta 7
Philadelphia 7
Secaucus 7
Wageningen 7
Ambivere 6
Bengaluru 6
Meppel 6
Abbiategrasso 5
Berlin 5
Central District 5
Elk Grove Village 5
Frankfurt am Main 5
Halle 5
Mountain View 5
Rochester 5
Taipei 5
Tappahannock 5
Torino 5
Zhengzhou 5
Andover 4
Barcelona 4
Bochum 4
Ciudad Nezahualcoyotl 4
Florianópolis 4
Harbin 4
Hong Kong 4
Lutz 4
Marburg 4
Osaka 4
Ottawa 4
Pescia 4
Sydney 4
São Paulo 4
Tokushima 4
Uetikon Am See 4
Zafra 4
Örebro 4
Auckland 3
Bangalore 3
Bangkok 3
Belo Horizonte 3
Braunschweig 3
Central 3
Flinders 3
Gangnam-gu 3
Genova 3
Totale 7.417
Nome #
Multi-strain Symbiotic Preparations as a Novel Adjuvant Approach to Allergic Rhinitis 244
Probiotics as a Novel Adjuvant Approach to Atopic Dermatitis 223
Multiple Drug Allergy Due to Hypersensitivity to Polyethylene Glycols of Various Molecular Weights 95
NAPPREB study protocol: A pivotal clinical trial to investigate clinical efficacy and potential response biomarkers to Benralizumab treatment in chronic rhinosinusitis with nasal polyps 95
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. 94
Research needs in allergy: an EAACI position paper, in collaboration with EFA 90
The accuracy of the HemoCue WBC DIFF in assessing blood eosinophils depends on the clinical setting and medical condition 90
Hypersensitivity to gelatin used as excipient for soft capsules of Ibuprofen 89
A critical appraisal on AIT in childhood asthma. 84
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD)-a EAACI position paper. 84
"Characteristics of patients admitted to emergency department for asthma attack: a real-LIFE study". 78
Exhaled nitric oxide measurements: correction equation to compare hand-held device to stationary analyzer 75
Macrogol hypersensitivity reactions during cleansing preparation for colon endoscopy. 71
Allergic sensitization to common pets (cats/dogs) according to different possible modalities of exposure: an Italian Multicenter Study. 71
An academic allergy unit during COVID-19 pandemic in Italy. 70
Very rapid improvement of extended nitric oxide parameters, associated with clinical and functional betterment, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) treated with Dupilumab 66
Allergy clinics in times of the SARS-CoV-2 pandemic: an integrated model 64
Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry. 61
Allergy to buckwheat: an emerging clinical problem. Clinical and laboratory analysis of 24 consecutive patients 61
Allergy in severe asthma. 59
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian Multicenter Study. 59
Allergy in internet 59
Evolving phenotypes to endotypes: is precision medicine achievable in asthma? 58
Unexplained chronic cough and vitamin B-12 deficiency. 58
Pertinence of requested allergy consultations for suspected food allergy/intolerance. A Junior Members working group of Italian Society of Allergy and Clinical Immunology (SIAIC) multicenter study. 57
Nasal nitric oxide concentration in suspected chronic rhinosinusitis 57
Nasal cytology: Methodology with application to clinical practice and research. 57
Adherence issues related to sublingual immunotherapy as perceived by allergists. 57
Breath analysis in patients with end-stage renal disease: effect of haemodialysis 56
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 56
A Bloody Mess: An Unusual Case of Diffuse Alveolar Hemorrhage Because of Warfarin Overdose 56
Allergic patients during the COVID-19 pandemic-Clinical practical considerations: An European Academy of Allergy and Clinical Immunology survey 55
Determinants of exhaled nitric oxide in chronic rhinosinusitis 55
Anaphylaxis after a horse bite 55
Immunological mechanisms underlying chronic rhinosinusitis with nasal polyps 54
Acute asthma management during SARS-CoV2-pandemic 2020 54
Anaphylaxis after eating italian pizza containing buckwheat as the hidden allergen 53
Is air pollution affecting the disease activity in patients with systemic lupus erythematosus? State of the art and a systematic literature review. 53
Level of exhaled nitric oxide during human anaphylaxis 53
Nasal nitric oxide in patients with inherited retinal dystrophies. 53
Microarray Immunodiagnostics for Aeroallergens 53
The Patient-Centered Decision System as per the 4Ps of Precision Medicine 53
Aligning the Good Practice MASK With the Objectives of the European Innovation Partnership on Active and Healthy Ageing 53
Oxidative stress and airway inflammation after allergen challenge evaluated by exhaled breath condensate analysis 52
Warning nonrespiratory symptoms in asthma: catastrophic abdominal involvement in a case of Churg-Strauss syndrome 52
Unexpected visitor: “hidden” food allergens 51
The Severe Asthma Network in Italy: Findings and Perspectives. 51
Exhaled nitric oxide as a clinical biomarker for choosing biologics for severe asthma treatment. 51
Strategies to reduce corticosteroid-related adverse events in asthma 51
One year of mepolizumab. Efficacy and safety in real-life in Italy 51
Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis 51
TNF-alpha: a promising therapeutic target for asthma? 50
Asthma from immune pathogenesis to precision medicine. 50
Real-life studies of biologics used in asthma patients: key differences and similarities to trials. 50
Acute urticaria presenting in the emergency room of a general hospital 50
Long-lasting clinical, radiological and immunological remission of severe nasal polyposis by means of 'reboot' surgery. 49
Interleukin-5 in the Pathophysiology of Severe Asthma. 49
EAACI consensus statement for investigation of work-related asthma in non-specialized centres 49
Exhaled nitric oxide in asthma. 48
Incidence of food anaphylaxis in Piemonte region (Italy): data from registry of Center for Severe Allergic Reactions. 48
Italian study on buckwheat allergy: prevalence and clinical features of buckwheat-sensitized patients in Italy 48
Treatable traits in chronic rhinosinusitis with nasal polyps 48
Usefulness of exhaled nitric oxide (FeNO) measured by a portable analyzer to diagnose cough variant asthma in a clinical setting of chronic cough 47
Minimal clinically important difference for asthma endpoints: an expert consensus report 47
Diagnostic classification of persistent rhinitis and its relationship to exhaled nitric oxide and asthma: a clinical study of a consecutive series of patients. 46
Validation of the Italian version of the Test of Adherence to Inhalers (TAI) 46
Eosinophils Target Therapy for Severe Asthma: Critical Points 46
Alveolar concentration and bronchial output of exhaled nitric oxide in chronic rhinosinusitis 46
The importance of being not significant: blood eosinophils and clinical responses do not correlate in severe asthma patients treated with Mepolizumab in real life. 46
The pathway towards asthma control 45
Omalizumab for Idiopathic Nonhistaminergic Angioedema: Evidence for Efficacy in 2 Patients. 45
Thunderstorm-related asthma epidemic owing to Olea Europaea pollen sensitization. 45
Omalizumab Treatment of Vernal Keratoconjunctivitis 45
Do the current guidelines for asthma pharmacotherapy encourage over-treatment? 45
Appropriateness in allergic respiratory diseases health care in Italy: definitions and organizational aspects 45
Pharmacoeconomic evaluation of oral corticosteroid adverse events in patients with severe asthma 45
Exhaled nitric oxide's ability to predict methacholine challenge: a matter of definition 44
Basophil activation test: a reliable biomarker for allergen immunotherapy? 44
Current insights in allergen immunotherapy. 44
Inhaled corticosteroids safety and adverse effects in patients with asthma 44
Predictors of reversible airway obstruction with omalizumab in severe asthma: a real-life study. 44
Asthma: personalized and precision medicine 44
Clinical manifestations, co-sensitizations, and immunoblotting profiles of buckwheat-allergic patients. 44
Exhaled nitric oxide as a marker of diseases 44
Choosing wisely in Allergology: a Slow Medicine approach to the discipline promoted by the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC) 44
Prevalence of over-/misdiagnosis of asthma in patients referred to an allergy clinic. 43
Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype 43
Exhaled nitric oxide in persistent rhinitis with or without lower airway involvement: a review of the literature. 43
Basophil Membrane Expression of Epithelial Cytokine Receptors in Patients with Severe Asthma. 43
Allergen immunotherapy for respiratory allergy: Quality appraisal of observational comparative effectiveness studies using the REal Life Evidence AssessmeNt Tool. An EAACI methodology committee analysis 43
Hypersensitivity reaction to human papillomavirus vaccine due to polysorbate 80. 42
Effect of arterial hypertension on chronic urticaria duration 42
Immunostimulants in respiratory diseases: focus on Pidotimod. 42
Extended nitric oxide analysis in patients with chronic rhinosinusitis with nasal polyps, with or without associated asthma 42
Alpha1-antitrypsin deficiency and asthma 42
Occupational asthma due to Neurospora sitophila sensitization in a coffee dispenser service operator 41
EUFOREA consensus on biologics for CRSwNP with or without asthma. 41
Exhaled nitric oxide (F(E)NO) in non-pulmonary diseases 41
Kounis syndrome: Aspects on pathophysiology and management 41
Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma 41
Totale 5.752
Categoria #
all - tutte 75.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 0 0 0 0 0 27
2020/20212.629 35 80 47 28 23 781 345 228 467 311 43 241
2021/20221.422 62 37 51 298 22 30 52 190 117 110 380 73
2022/20233.681 550 149 348 416 354 295 26 290 657 297 234 65
2023/20242.110 183 242 437 66 114 184 90 136 63 60 176 359
2024/2025264 131 105 28 0 0 0 0 0 0 0 0 0
Totale 10.133